Cargando…
Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera
Autores principales: | Wei, Jenny J., Kallenbach, Lisa R., Kreider, Maryl, Leung, Thomas H., Rosenbach, Misha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453827/ https://www.ncbi.nlm.nih.gov/pubmed/31008168 http://dx.doi.org/10.1016/j.jdcr.2019.02.006 |
Ejemplares similares
-
Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera
por: Yikilmaz, Aysun Şentürk, et al.
Publicado: (2020) -
Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
por: Alam, Mariam, et al.
Publicado: (2020) -
Stable Extent of Recurrently Active Cardiac and Cutaneous Sarcoidosis
por: Patterson, Karen C., et al.
Publicado: (2021) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
por: Talty, Ronan, et al.
Publicado: (2021) -
Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016)